Tower Research Capital LLC (TRC) - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 3 filers reported holding CASI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$2,000
-50.0%
2,091
-62.6%
0.00%
Q4 2021$4,000
-93.8%
5,593
-89.7%
0.00%
-100.0%
Q3 2021$64,000
+814.3%
54,101
+1144.8%
0.00%
Q2 2021$7,000
-50.0%
4,346
-25.9%
0.00%
Q1 2021$14,000
-74.1%
5,862
-67.7%
0.00%
-100.0%
Q4 2020$54,000
-43.8%
18,150
-71.1%
0.00%
+100.0%
Q3 2020$96,000
+242.9%
62,808
+463.4%
0.00%0.0%
Q2 2020$28,000
+2700.0%
11,149
+4944.8%
0.00%
Q4 2019$1,000
-80.0%
221
-85.3%
0.00%
Q3 2019$5,000
-16.7%
1,500
-13.3%
0.00%
Q2 2019$6,000
-83.8%
1,730
-86.5%
0.00%
-100.0%
Q1 2019$37,000
+428.6%
12,839
+633.7%
0.00%
+100.0%
Q4 2018$7,000
-75.0%
1,750
-70.7%
0.00%
-50.0%
Q3 2018$28,000
+2700.0%
5,974
+895.7%
0.00%
Q4 2015$1,0000.0%600
+100.0%
0.00%
Q2 2015$1,000
-80.0%
300
-90.9%
0.00%
-100.0%
Q1 2015$5,000
+400.0%
3,308
+480.4%
0.00%
Q4 2014$1,0005700.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$23,522,00027.18%
Consonance Capital Management LP 7,576,431$22,350,0002.09%
Wellington Shields & Co., LLC 1,812,769$5,348,0001.92%
Wellington Shields Capital Management, LLC 2,071,765$6,112,0000.82%
Ikarian Capital, LLC 1,268,154$3,741,0000.16%
Sio Capital Management, LLC 203,432$600,0000.12%
Zebra Capital Management LLC 11,182$33,0000.04%
FEDERATED HERMES, INC. 7,000,000$20,650,0000.04%
GSA CAPITAL PARTNERS LLP 52,146$154,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 161,949$478,0000.02%
View complete list of CASI PHARMACEUTICALS INC shareholders